Fintel reports that on October 10, 2025, Needham reiterated coverage of InMode (NasdaqGS:INMD) with a Hold recommendation.

InMode will host a conference call to discuss the third quarter 2025 financial results on Wednesday, November 5, 2025, at ...

Shares of InMode Ltd. (NASDAQ:INMD) climbed 9% on Thursday after the medical technology company released preliminary ...

The InMode (NASDAQ:INMD) stock crash today is enough to send shivers down the spine of any investor. Yet, there's a value play here for anyone willing to accept some risk. I am bullish on INMD stock ...

InMode (INMD) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Yokneam, Israel-based Inmode Ltd. has filed with the SEC a preliminary prospectus to offer 5 million shares in an IPO, with the price range estimated to be between $14 and $16. At the mid-point of the ...

New revenue guidance implies another year of decline (-6%), keeping the stock price locked in the $14 range (-15% YTD). International sales are accelerating, likely to drive a return to growth by 2026 ...

InMode's stock price has dropped significantly from its peak in 2021, despite consistently strong operational performance. In the meantime, the company's strong profitability has led to InMode ...

YOKNEAM, Israel, July 10, 2025 /PRNewswire/ --InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results ...

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable ...